NextGen BioMed

Speaker: Fabien Rousset, Director Global Innovation

The global rise in peptide demand, driven by accelerated clinical development and speed to market pressures, requires a rethinking of traditional peptide manufacturing. Process Intensification (P.I.) provides a structured approach to increasing output, minimizing costs, with a focus on flexibility and sustainability. This presentation will highlight some P.I. tools as single-unit operations or in combinatorial scenario with other technologies under evaluation.